CD80 and atherosclerosis: In the following decade, studies on blood vessel diseases and effective strategies for tolerance induction based on costimulatory blockade appeared to be attainable.[149] As a chronic disease, atherosclerosis has raised questions about the practicality of immune therapy in the costimulatory and coinhibitory pathways of the B7-CD28 family.